Advisor Group Holdings, Inc. Electro Core, Inc. Transaction History

Advisor Group Holdings, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.21 - $5.63 $1,050 - $28,150	5,000 Added 277.78%	6,800 $1,000
Q3 2022 Nov 14, 2022	SELL	$0.46 - $6.75 $138 - $2,025	-300 Reduced 14.29%	1,800 $1,000
Q1 2022 May 04, 2022	BUY	$0.5 - $0.88 $300 - $528	600 Added 40.0%	2,100 $1,000
Q3 2021 Nov 05, 2021	BUY	$0.93 - $1.18 $465 - $590	500 Added 50.0%	1,500 $2,000
Q1 2021 May 13, 2021	SELL	$1.62 - $3.05 $3,240 - $6,100	-2,000 Reduced 66.67%	1,000 $2,000
Q3 2020 Nov 12, 2020	BUY	$0.8 - $2.33 $2,160 - $6,291	2,700 Added 900.0%	3,000 $5,000
Q2 2020 Aug 14, 2020	BUY	$0.75 - $1.29 $225 - $387	300 New	300 $0

143K

Ticker ECOR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 71,176,896
Market Cap $1.09B
Description
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults....

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.